Print Page     Close Window     

SEC Filings

10-K/A
BIOTIME INC filed this Form 10-K/A on 03/29/2017
Entire Document
 

10.9
 
Amended and Restated Research and License Agreement, dated October 7, 2010, between Hadasit Medical Research Services and Development Ltd. and Cell Cure Neurosciences Ltd. (11)
     
10.10
 
Additional Research Agreement, dated October 7, 2010, between Hadasit Medical Research Services and Development Ltd. and Cell Cure Neurosciences Ltd. (11)
     
10.11
 
OrthoCyte Corporation 2010 Stock Option Plan; Form of OrthoCyte Corporation Stock Option Agreement (11)
     
10.12
 
BioTime Asia, Limited 2010 Stock Option Plan; Form of BioTime Asia Limited Stock Option Agreement (11)
     
10.13
 
License Agreement between BioTime, Inc. and Cornell University (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) (12)
     
10.14
 
LifeMap, Inc. 2011 Stock Option Plan; and Form of LifeMap, Inc. Stock Option Agreement (13)
     
10.15
 
Exclusive License Agreement, dated February 15, 2006, between Glycosan BioSystems, Inc. and the University of Utah Research Foundation, as amended (14)
     
10.16
 
Form of Employee Incentive Stock Option Agreement (15)
     
10.17
 
Form of Non-employee Director Stock Option Agreement (15)
     
10.18
 
Option Agreement, dated March 4, 2014, between BioTime and certain investors (16)
     
10.19
 
Co-Development and Option Agreement, dated May 6, 2014, between LifeMap Solutions, Inc. and the Icahn School of Medicine at Mount Sinai (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) (17)
     
10.20
 
LifeMap Solutions, Inc. 2014 Stock Option Plan (17)
     
10.21
 
Form of LifeMap Solutions, Inc. Incentive Stock Option Agreement (17)
     
10.22
 
Form of LifeMap Solutions, Inc. Stock Option Agreement (17)
     
10.23
 
Employment Agreement, dated December 29, 2014, between BioTime, Inc. Aditya Mohanty (18)
     
10.24
 
First Amendment to Co-Development and Option Agreement, dated March 7, 2015, between Icahn School of Medicine at Mount Sinai and LifeMap Solutions, Inc. (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) (19)
     
10.25
 
2012 Equity Incentive Plan, as amended (20)
     
10.26
 
Stock Purchase Agreements, dated September 14, 2015, between BioTime, Inc. and certain investors (21)
     
10.27
 
Research & Development Agreement, dated September 29, 2015, between OrthoCyte Corporation and Heraeus Medical GmbH (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) (21)
     
10.28
 
License Agreement, dated September 29, 2015, between OrthoCyte Corporation and Heraeus Medical GmbH (Portions of this exhibit have been omitted pursuant to a request for confidential treatment) (21)
 

© Copyright BioTime, Inc.